Non-Small-Cell Lung Cancer (cont.)
Exams and Tests
Medical evaluation and tests
The symptoms of lung cancer can be caused by many different medical conditions. Even a chest X-ray film that shows what looks like a tumor is not enough to make the diagnosis of lung cancer. The health care provider’s job is to gather all available information and to make the diagnosis. Correct and prompt diagnosis is essential so that appropriate treatment can be started as soon as possible.
The first step in the evaluation is the medical interview. The health care provider asks the patient questions about symptoms and when they started, current or past medical problems, medications taken, family medical problems, work and travel history, and habits and lifestyle. This is followed by a thorough physical examination.
The remainder of the evaluation focuses on confirming the presence of lung cancer and staging the tumor. Although primary care providers are able to conduct this evaluation, they may prefer to refer the patient a specialist. At any time during this evaluation, the primary care provider may refer the patient to a surgeon or to a specialist in lung diseases (pulmonologist) or cancer (oncologist).
No blood test can confirm that a patient has lung cancer. Blood tests are performed to check the patient’s general health, to rule out other conditions that might cause similar symptoms, and to detect certain paraneoplastic syndromes. The usual blood tests include the following:
- Complete blood cell counts
- Liver and kidney function tests
- Blood chemistry and electrolyte levels
Respiratory (breathing) symptoms are usually evaluated with a chest X-ray film, CT scan of the chest, or both. X-ray films are limited in the amount of detail they provide, but they clearly show some tumors. CT scans shows much greater detail in a 3-dimensional format. A CT scan is needed if the X-ray film findings are not definitive. If imaging studies show evidence of a tumor, further testing is needed.
Other tests Sputum analysis: Sputum is mucus in the lungs. Sputum is the body’s natural system for removing small particles and contaminants from the airways. Many people, especially those who smoke, produce sputum when they cough. In some cases of lung cancer, tumor cells are sloughed off into the sputum and can be detected by cytologic (cell) testing. For this test, the patient is asked to cough, and the sputum is collected and examined.
- This simple test, if the result is positive for tumor cells, confirms the diagnosis of cancer. A result negative for tumor cells, however, does not confirm that no cancer is present.
- In either case, further testing is needed: if positive for tumor cells, to determine the type of cancer; if negative for tumor cells, to seek definitive evidence of whether a tumor is present.
Bronchoscopy: This is the use of a device called an endoscope to view the lungs directly. An endoscope is a thin tube with a light and a tiny camera on the end. The endoscope is inserted through the mouth or nose into the bronchus (airway) and down to the lung. The camera transmits pictures of the inside of the patient’s airways that can be viewed on a video screen.
- Bronchoscopy allows the doctor to look directly at the tumor (if one is present). This allows the doctor to determine the tumor’s size and the extent to which it is blocking the airway.
- The bronchoscope can also be used to collect a biopsy. A biopsy is a small sample of the tumor or any abnormal-appearing lung tissue, for further testing.
- The biopsy is examined under a microscope by a pathologist, a specialist in diagnosing diseases in this way. The pathologist confirms whether the mass is cancer and, if so, the type of cancer.
- This technique is also used to examine the area around the main airway, between the lungs in the middle of the chest (mediastinum). The cancer can infiltrate the lymph nodes in this area. The endoscope is inserted through a small incision just above or to the side of the breastbone. This technique is called mediastinoscopy. Enlarged lymph nodes and other abnormal tissues can be removed during this procedure.
CT-guided biopsy: This procedure involves a CT scan to guide the removal of a biopsy. It is used for tumors that cannot be reached with a bronchoscope, usually because they are in the outer part of the lung. Again, this material is examined to confirm the presence of a tumor and to determine the type of tumor.
Biopsies from other sites: Material can also be obtained from other sites with abnormalities to confirm the diagnosis. These sites include enlarged lymph nodes or liver and collections of fluid around the lung (pleural effusion) or heart (pericardial effusion). Staging
Staging is a system of classifying cancers based on the extent of the disease. In general, the lower the stage, the better the outlook for remission and survival. In NSCLC, staging is based on the size of the primary tumor, the number of cancerous lymph nodes, and the presence of any metastatic tumors. Accurate staging is essential in NSCLC because the stage of the cancer determines which treatment may offer the best results.
For people with lung cancer, the first step is to undergo a staging evaluation. The patient’s medical team cannot make recommendations for the best treatment until they know the cancer’s exact stage.
This evaluation includes many of the tests already described. Other tests are as follows:
- CT scan of the chest and upper abdomen: The purposes of this scan are to measure the exact size of the primary tumor, to look for enlarged lymph nodes that may be cancerous, and to look for signs of metastatic disease in the liver and adrenal glands.
- CT scan or MRI of the brain: This is needed only if the patient is experiencing neurologic symptoms that suggest that the cancer has metastasized to the brain.
- Positron emission tomography (PET) scan: This scan detects cancer cells throughout the body based on the rate they use glucose (sugar); this rate is higher than that of normal cells. PET scan is
relatively widely available and of major importance for proper staging and
- Bone scan: This test, formally known as scintigraphy, looks for metastasis to the bones. A harmless radioactive substance is inserted into the bloodstream. It concentrates in areas where the infiltrating cancer has weakened the bone. A scan of the entire skeleton highlights these areas. Generally, this test is performed only if the patient is experiencing bone pain or other signs of bony metastasis.
- MRI of the spine: MRI is the best test for
detecting compression of the spinal cord. This happens when the metastatic disease
puts pressure on the spinal cord. Cancer which has spread to the spinal column
of bones can weaken the bones and lead to this complication. This is a serious complication of lung cancer. It usually causes pain in the neck, back, or hip. Compression of the spinal cord can also cause numbness or paralysis in the arms, legs, or both; problems controlling bladder or bowels; and other problems.
If not quickly relieved, the damage can become permanent.
The stage is determined by a combination of the following 3 characteristics:
- T - Size and extent of primary tumor (X,1,2,3,4)
- N - Involvement of lymph nodes in the region of the lungs (0,1,2,3)
- M - Metastatic involvement
For each tumor, a number is assigned for each of the 3 letters—for example, T2N1M0. These 3 numbers determine the stage. NSCLC has 4 stages, designated I, II, III, and IV. Stages I-III are subdivided into A and B subtypes. The stage groupings are as follows:
- IA: T1N0M0; The tumor is limited to the lung, and the tissue around the tumor is normal.
- IB: T2N0M0; The tumor is limited to the lung but is larger than in stage IA. The tissue around the tumor is normal.
- IIA: T1N1M0; The tumor has spread to the area around the lung, such as lymph nodes, the chest wall, the diaphragm, or the sacs surrounding the lung or heart.
- IIB: T2N1M0, T3N0M0; This stage is similar to stage IIA but the tumor is larger or nearby lymph nodes are involved.
- IIIA: T1-3N2M0, T3N1M0; The tumor has spread to the lymph nodes in the mediastinum, on the other side of the chest, or in the lower neck.
- IIIB: Any T4 or any N3M0; This stage is similar to stage IIIA but the tumor is larger.
- IV: Any M1; Tumor has spread to another section of the lungs or elsewhere in the body.
NonSmall-Cell Lung Cancer Treatment
Tissue diagnosis is mandatory prior to any treatment. The goals of treatment are to remove or shrink the tumor, to kill all residual tumor cells, to prevent or minimize complications and paraneoplastic syndromes, and to relieve the symptoms and side effects associated with the disease and treatment. Available therapies cure only a small number of people with lung cancer. Other people’s tumors shrink substantially or even disappear, although residual cancer cells remain in the body. This is called remission. Most people feel well during remission and are able to resume their everyday activities. Remissions can last a few months, a few years, or even indefinitely. If and when the disease comes back, it is called recurrence or relapse. The disease may recur in the lung or in another part of the body. A loss of weight of more than 5% indicates a poor prognosis.
Medically Reviewed by a Doctor on 9/11/2014
Koyamangalath Krishnan, MD, FRCP
Must Read Articles Related to Non-Small-Cell Lung Cancer
Small-Cell Lung Cancer
When cells of the lung start growing rapidly in an uncontrolled manner, the condition is called lung cancer. Lung cancer can affect any part of the lung. Lung c...learn more >>
Understanding Lung Cancer Medications
Medical therapy options for lung cancer include surgery, radiation, and/or chemotherapy. These treatments help decrease tumor growth and size. When tumor growth...learn more >>
Patient Comments & Reviews
The eMedicineHealth doctors ask about Non-Small-Cell Lung Cancer: